Digital Health market Research Report by 2022, Forecast till 2035

Detailed Information

The “Digital Health Market: Focus on Digital Therapeutics (3rd Edition), 2023-2035” report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of digital therapeutics solutions (either commercialized or under development) in the healthcare industry, over the next decade.

The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Key Inclusions
 An executive summary of the key insights captured during our research, offering a high-level view on the current state of the digital therapeutics market and its likely evolution in the short to mid and long term.
 A brief introduction to important concepts related to digital therapeutics, featuring information on various types of digital therapeutics and its primary applications in the healthcare domain. Further, this chapter features details related to the recent advancements that have been reported in this market space.
 An overview of the current market landscape of digital therapeutic solutions, including information on status of development, type of solution (combination offering of software application and device or AI or personal coach, and standalone software application), type of therapy (curative and preventive), purpose of solution (medication replacement and medication augmentation), target indication(s), therapeutic area and target population. In addition, it presents details related to the companies engaged in developing digital therapeutic solutions, highlighting their year of establishment, company size, type of business model (B2B and B2C) and location of their headquarters.
 An in depth analysis, highlighting the contemporary market trends, using three schematic representation, including a 4-D bubble analysis for comparing the leading players engaged in the development of digital therapeutic solutions (based on the parameters, such as product portfolio strength, number of target indication(s) and company size), an insightful tree map representation of the digital therapeutic solutions (distributed on the basis of therapeutic area and company size), and a world map representation (highlighting the regional distribution of developer companies).
 A detailed product competitiveness analysis of digital therapeutic solutions that are available / under development for the most popular therapeutic areas, taking into consideration strength of the product portfolio (based on the number of digital therapeutic solutions being developed for that therapeutic area) and key product specific parameters, such as status of development, type of solution, type of therapy, prescription requirement and purpose of solution.
 Elaborate profiles of prominent large, mid-sized and small players that are either engaged in the development or have developed digital therapeutic solutions. Each company profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective product portfolio, recent developments and an informed future outlook.
 An analysis of completed, ongoing and planned clinical studies of digital therapeutics, various relevant parameters, such as trial registration year, trial phase, number of patients enrolled, study design, trial recruitment status and trial focus, type of organization, and regional distribution of trials. In addition, it features an insightful clinical end-points analysis (for top ten recent initiated trials for popular therapeutic areas).
 An analysis of funding and investments received by players engaged in the digital therapeutics’ domain, during the period 2016-2022, including grants, debt financing, seed funding, venture series, initial public offering, secondary offerings, private placements and other equity.
 An in-depth analysis of partnerships that have been inked between various stakeholders during the period 2016-2022, covering marketing and distribution agreements, mergers / acquisitions, pilot product offerings, product / technology integration agreements, product / technology licensing agreements, product development agreements, product evaluation agreements, product training agreements, product development agreements, research and development agreements, and commercialization agreements.
 A detailed analysis of various business models and go-to-market strategies adopted by firms engaged in developing digital therapeutic solutions, highlighting details on various channels adopted by the stakeholders in order to raise awareness and offer access to their proprietary products.
 A Bowman’s clock pricing strategy framework analyzes the competitive position of various companies engaged in this domain, taking into consideration the prices and different features of their products. In addition, it presents an equation devised to calculate the likely price of digital therapeutics based upon their characteristics.
 A detailed market forecast analysis in order to estimate the existing market size and the future opportunity for digital therapeutics developers over the next decade. Based on multiple parameters, likely adoption trends and expected price variations of these products, we have provided an informed estimate of the evolution of the market for the period 2023-2035. The report also features the likely distribution of the current and forecasted opportunity within the digital therapeutics market across type of solution (combination offering of software application and device or AI or personal coach, and standalone software applications), purpose of solution (medication replacement and medication augmentation), type of therapy (curative and preventive), business models (B2C (patients) and B2B (healthcare providers, payers, employers and pharmaceutical companies)), therapeutic area (cardiovascular disorders, chronic pain, mental health problems, metabolic disorders, neurological disorders, respiratory disorders, sleep disorders, substance use disorders, and other disorders), and key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
 A detailed assessment of the overall market landscape of women’s digital health solution developers, along with information on their year of establishment, company size, location of headquarters, type of solution(s) offered (applications / software, devices and services), along with their current status of development, product ratings, application area, usage during different stages of pregnancy, purpose of solution and type of end-users.
 A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall digital therapeutic solutions industry.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

 Type of Solution
 Standalone Software Application
 Software Application + Device + Personal Coach
 Software Application + Device + AI Support
 Software Application + Device
 Software Application + AI Support
 Software Application + Personal Coach
 Other Types of Solutions

 Purpose of Solution
 Medication Replacement
 Medication Augmentation

 Type of Therapy
 Curative
 Preventive

 Business Model
 Business to Consumer
 Business to Business

 Therapeutic Areas
 Cardiovascular Disorders
 Chronic Pain
 Mental Health Problems
 Metabolic Disorders
 Neurological Disorders
 Respiratory Disorders
 Sleep Disorders
 Substance Use Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia
 Middle East and North Africa
 Latin America
 Rest of the world

Key Questions Answered
 What are the most popular therapeutic areas being targeted by digital therapeutics?
 What is the future of digital therapeutics in pharma?
 Which region is leading in the digital therapeutics market?
 What are the key factors influencing the price of digital therapeutic solutions?
 What is the trend of capital investments in the digital therapeutics market?
 Which types of partnerships are usually signed in the digital therapeutics industry?
 Which marketing strategies are commonly adopted for digital therapeutics?
 How is the current and future opportunity likely to be distributed across key market segments?

To view more details on this report, click on the link

You may also be interested in the following titles:
Conjugation and Labeling Services Market

Bispecific Antibodies Market
Digital Biomanufacturing Market

Global Gene Switch Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Ben Johnson
+1 (415) 800 3415